A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells (Q39847833)

From Wikidata

Revision as of 23:37, 1 March 2024 by MidleadingBot (talk | contribs) (‎Changed Asturian description: artículu científicu espublizáu en 2009, batch #225732)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

author name string

Atsushi Yamanaka

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Eiji Konishi

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

17 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3735-3743

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Immunopathological mechanisms in dengue and dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical Consultation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Virus isolation as one of the diagnostic methods for dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

A Heterologous DNA Prime-Venezuelan Equine Encephalitis Virus Replicon Particle Boost Dengue Vaccine Regimen Affords Complete Protection from Virus Challenge in Cynomolgus Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Models of dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Mouse models of dengue virus infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Liver injury and viremia in mice infected with dengue-2 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Manifestation of thrombocytopenia in dengue-2-virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Development of a novel mouse model for dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Dengue Fever in Humanized NOD/SCID Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

CLEC5A is critical for dengue-virus-induced lethal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Infection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement Levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

New mouse model for dengue virus vaccine testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.083

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.03.083

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39847833&oldid=2091440671"